Stem Cell Study for Long COVID-19 Neurological Symptoms

Clinical trial NCT06156241 · UNKNOWN

Trial details

NCT number: NCT06156241
Sponsor: Charles Cox
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Post-Acute COVID-19 Syndrome

Start date: 2024-01-01
Primary completion: 2025-12-01
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.